XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (23,775) $ (7,794)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 253 96
Stock-based compensation expense 4,111 267
Write-down of inventory 0 75
Payments received on net investment in lease 2 3
Changes in assets and liabilities:    
Accounts receivable (1,391) (467)
Unbilled receivables (387) (8)
Inventory (228) (672)
Prepaid expenses and other current assets (1,848) (326)
Due from related parties 13 882
Prepaid inventory   (16)
Other long term assets 11 (7)
Accounts payable (565) 169
Deferred grant funding (679)  
Deferred revenue 584 600
Due to related parties (1,884) 19
Accrued expenses and other current liabilities (1,506) (307)
Net cash used in operating activities (27,289) (7,486)
Cash flows from investing activities:    
Purchases of fixed assets (308) (170)
Net cash used in investing activities (308) (170)
Cash flows from financing activities:    
Proceeds from exercise of stock options   49
Proceeds from issuance of Series D convertible preferred stock   30,468
Stock issuance costs related to Series D convertible preferred stock   (7)
Investment from 4Bionics, LLC   700
Net cash provided by financing activities   31,210
Net (decrease) increase in cash and cash equivalents and restricted cash (27,597) 23,554
Cash, cash equivalents and restricted cash, beginning of period 191,160 64,286
Cash, cash equivalents and restricted cash, end of period 163,563 87,840
Reconciliation of cash, cash equivalents, and restricted cash reported in the statement of financial position    
Cash and cash equivalents 161,580 86,230
Restricted cash 1,983 1,610
Total cash, cash equivalents and restricted cash 163,563 87,840
Supplemental disclosure of cash flow information:    
Cash received from exchange of research and development tax credits   324
Supplemental disclosure of noncash information:    
Noncash acquisition of fixed assets 62 $ 58
Write-off of notes receivable $ 90